Oct. 12, 2022
In a quick turnaround, CMS rescinded its September 26, 2022 memo and has decided it will continue to exercise its enforcement discretion under CLIA for the duration of the COVID-19 public health emergency for the use of SARS-CoV-2 molecular and antigen point of care (POC) tests on asymptomatic individuals outside of the test’s authorization.
These materials have been prepared for informational purposes only and are not legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Internet subscribers and online readers should not act upon this information without seeking professional counsel.